Diagnos Laboratorium Utama Tbk. vs Samindo Resources Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Samindo Resources Tbk. trades at Rp1,045 (market cap 2.32T, 54.4K 24h volume). The key difference: Samindo Resources Tbk. is far larger — about 7.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 54.4K). Which is the better fit depends on your goals.
| DGNS | MYOH | |
|---|---|---|
Market Cap | 310.75B | 2.32T |
Volume | 963.6K | 54.4K |
Lot | 9.64K | 544 |
Turnover | 217.67M | 56.78M |
Average Price | 225.89 | 1,043.82 |
Value | 217.67M | 56.78M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Samindo Resources Tbk formerly PT Myoh Technology Tbk domiciled in Jakarta, was established on March 15, 2000 based on a Notarial Deed No. 37 of Ester Mercia Sulaiman, S.H.
Read more on MYOH →